Skip to content

Comparison of effects of Oxytocin and Carbetocin in women undergoing LSCS

A comparative study of hemodynamic effects of Oxytocin and Carbetocin in women undergoing lower segment cesarean section under spinal anaesthesia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084848
Enrollment
174
Registered
2025-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Oxytocin: Oxytocin is a uterotonic with rapid onset of action but relatively shorter acting. Patient will recieve 10 IU of IV Oxytocin diluted in 10 ml Normal Saline, 5 IU will be given

Sponsors

Banaras Hindu University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Term gestation between 37 weeks to 42 weeks undergoing elective LSCS

Exclusion criteria

Exclusion criteria: 1- Conditions of fetal distress 2- Patients with systemic diseases 3- Hydramnios (oligo or poly hydramnios) 4- Placenta previa 5- Ecclampsia, pre ecclampsia 6- Gestational diabetes mellitus 7- Prematurity 8- Borderline cephalo pelvic disproportion 9- Previous classical CS or any other major surgery on uterus 10- Patients undergoing LSCS under GA

Design outcomes

Primary

MeasureTime frame
Compare the differences in haemodynamic responses using Mean Arterial Pressure (MAP) among both the groups before and after administration of uterotonics after delivery of baby.Timepoint: Baseline, 30 sec after, 1 min, 5 min, 10 min, 15 min and 30 min after administration of uterotonic after delivery of baby.

Secondary

MeasureTime frame
1- Compare other haemodynamic parameters like Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Heart rate (HR), Oxygen saturation (SpO2) and compare need for vasopressor support after administration of uterotonic after delivery of baby, 2- Compare level of uterine contraction achieved and if any additional dose of uterotonics is required, 3- Compare the amount of blood loss and requirement of transfusion if any.Timepoint: Baseline, 30 sec after, 1 min, 5 min, 10 min, 15 min and 30 min after administration of uterotonic after delivery of baby

Countries

India

Contacts

Public ContactDr Abhinay Jayanthi

Institute of Medical Sciences, BHU

abhinay2288@gmail.com7379141929

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026